Literature DB >> 26291011

Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma.

Jung-Jyh Hung1, Yi-Chen Yeh2, Wen-Juei Jeng3, Hong-Che Chien4, Yu-Chung Wu4, Teh-Ying Chou2, Wen-Hu Hsu5.   

Abstract

OBJECTIVE: Recurrence after surgical resection is the most common cause of treatment failure in patients with non-small-cell lung cancer. The aim of the study is to investigate the prognostic factors of postrecurrence survival (PRS) in patients of resected lung adenocarcinoma.
METHODS: The clinicopathological characteristics of 179 patients with recurrence after complete resection of lung adenocarcinoma at Taipei Veterans General Hospital between 2004 and 2010 were retrospectively reviewed. The prognostic and predictive effects of these clinicopathological variables in PRS were analyzed.
RESULTS: The pattern of recurrence included local only in 25 (15.4%), distant only in 56 (34.6%), and both local and distant in 81 (50.0%) of patients. The 2-year and 5-year PRS were 65.2% and 29.8%, respectively. The most common organ sites of metastasis were the contralateral lung (39.1%), followed by the brain (33.5%) and the bone (31.3%). Multivariate analysis revealed that micropapillary/solid predominant pattern group (versus acinar/papillary; hazard ratio = 2.615; 95% confidence interval: 1.395-4.901; p = 0.003) and no treatment for recurrence (p < 0.001) were significant prognostic factors of worse PRS. For patients receiving treatment for recurrence, micropapillary/solid predominant pattern group (versus acinar/papillary; hazard ratio = 2.570; 95% confidence interval: 1.357-4.865; p = 0.004) was a significant predictive factor of worse PRS. Treatment for recurrence with surgery (p = 0.067) tended to be a significant predictive factor of better PRS.
CONCLUSIONS: In lung adenocarcinoma, micropapillary/solid predominant pattern group (versus acinar/papillary) was a significant poor prognostic factor for PRS.

Entities:  

Mesh:

Year:  2015        PMID: 26291011     DOI: 10.1097/JTO.0000000000000618

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  12 in total

1.  Prognostic Factors for Post Recurrence Survival in Resected Pathological Stage I Non-small Cell Lung Cancer.

Authors:  Yasuaki Kubouchi; Yoshiteru Kidokoro; Takashi Ohno; Yohei Yurugi; Makoto Wakahara; Tomohiro Haruki; Hiroshige Nakamura
Journal:  Yonago Acta Med       Date:  2018-02-05       Impact factor: 1.641

2.  Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery.

Authors:  Abraham J Wu; Elizabeth Garay; Amanda Foster; Meier Hsu; Zhigang Zhang; Jamie E Chaft; James Huang; Kenneth E Rosenzweig; Andreas Rimner
Journal:  Clin Lung Cancer       Date:  2017-02-21       Impact factor: 4.785

3.  Platelet Count is Associated with the Rate of Lymph Node Metastasis in Lung Adenocarcinoma.

Authors:  Cheng-Hao Qu; Tong Li; Zhan-Peng Tang; Xi-Rui Zhu; Jing-Yi Han; Hui Tian
Journal:  Cancer Manag Res       Date:  2020-10-07       Impact factor: 3.989

4.  Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study.

Authors:  Xuan-Qi Zheng; Jin-Feng Huang; Jia-Liang Lin; Liang Chen; Ting-Ting Zhou; Dong Chen; Dong-Dong Lin; Jian-Fei Shen; Ai-Min Wu
Journal:  Transl Lung Cancer Res       Date:  2019-08

5.  Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer.

Authors:  Tetsuya Mizuno; Takaaki Arimura; Hiroaki Kuroda; Noriaki Sakakura; Yasushi Yatabe; Yukinori Sakao
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

6.  Metastatic spread of solid subtype lung adenocarcinoma to the small intestine with anemia and melena: A case report.

Authors:  Xiaofang Ying; Mingwei Wang; Vivek Verma; Manxiang Wang; Shengwei Ye; Jianping Bi; Xiaoyi Zhou; Guang Han; Weining Zhen
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

7.  Inhibition of DOT1L by Half-Selenopsammaplin A Analogs Suppresses Tumor Growth and EMT-Mediated Metastasis in Triple-Negative Breast Cancer.

Authors:  Woong Sub Byun; Gyu Ho Lee; Hyeung-Geun Park; Sang Kook Lee
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-28

Review 8.  Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review.

Authors:  Ying Cao; Li-Zhen Zhu; Meng-Jie Jiang; Ying Yuan
Journal:  Onco Targets Ther       Date:  2015-12-31       Impact factor: 4.147

9.  Prognostic significance of basal versus superior segment in patients with completely resected lung adenocarcinoma in the lower lobe.

Authors:  Yi-Han Lin; Jung-Jyh Hung; Yi-Chen Yeh; Wen-Hu Hsu
Journal:  Thorac Cancer       Date:  2019-01-02       Impact factor: 3.500

Review 10.  [Pathological and Molecular Features of Lung Micropapillary Adenocarcinoma].

Authors:  Jiafeng Liang; Qiong Wu; Shenglin Ma; Shirong Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.